Single User License
INR 337113
Site License
INR 674225
Corporate User License
INR 1011338

Service Tax Additional

select a format
Price

Single User License
USD 4995
Site License
USD 9990
Corporate User License
USD 14985

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


United States Computed Tomography (CT) Systems Market Outlook to 2022

United States Computed Tomography (CT) Systems Market Outlook to 2022


  Request for Sample Report

Executive Summary

United States Computed Tomography (CT) Systems Market Outlook to 2022

Summary

GlobalData's new report, "United States Computed Tomography (CT) Systems Market Outlook to 2022", provides key market data on the United States Computed Tomography (CT) Systems market. The report provides value, in millions of US dollars, volume (in units) and and average prices (USD) within market segements-256-320 slice CT Systems, 128-slice CT Systems, 64-slice CT Systems, 20-40 slice CT Systems and 16-slice and below CT Systems.

The report also provides company shares and distribution shares data for each of these market segements, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

Market size and company share data for Computed Tomography (CT) Systems market segements-256-320 slice CT Systems, 128-slice CT Systems, 64-slice CT Systems, 20-40 slice CT Systems and 16-slice and below CT Systems.

Annualized market revenues (USD million) and volume (units) data for each of the market segements. Data is provided from 2008 to 2015 and forecast to 2022.

2015 company shares and distribution shares data for each of the market segements.

Global corporate-level profiles of key companies operating within the United States Computed Tomography (CT) Systems market.

Key players covered include Siemens Limited, GE Healthcare Limited, Toshiba Medical Systems Corporation and Others.

Reasons To Buy

Develop business strategies by identifying the key market segments poised for strong growth in the future.

Develop market-entry and market expansion strategies.

Design competition strategies by identifying who-stands-where in the market.

Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

What are the key distribution channels and what's the most preferred mode of product distribution-Identify, understand and capitalize.

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 6

1.2 List of Figures 6

2 Introduction 7

2.1 What Is This Report About? 7

2.2 Computed Tomography (CT) Systems Market Segmentation 7

2.3 Definitions of Markets Covered in the Report 8

3 Computed Tomography (CT) Systems Market, United States 9

3.1 Computed Tomography (CT) Systems Market, United States, Revenue ($m), 2008-2015 9

3.2 Computed Tomography (CT) Systems Market, United States, Revenue ($m), 2015-2022 11

3.3 Computed Tomography (CT) Systems Market, United States, Volume (Units), 2008-2015 13

3.4 Computed Tomography (CT) Systems Market, United States, Volume (Units), 2015-2022 15

3.5 Computed Tomography (CT) Systems Market, United States, Average Price ($), 2008-2022 17

3.6 Computed Tomography (CT) Systems Market, United States, Distribution Share by Revenue ($m), 2014-2015 19

3.7 Computed Tomography (CT) Systems Market, United States, Company Share by Revenue ($m), 2015 20

4 Overview of Key Companies in United States, Computed Tomography (CT) Systems Market 22

4.1 Siemens Limited 22

4.1.1 Company Overview 22

4.2 GE Healthcare Limited 22

4.2.1 Company Overview 22

4.3 Toshiba Medical Systems Corporation 22

4.3.1 Company Overview 22

4.4 Philips Healthcare 23

4.4.1 Company Overview 23

5 Computed Tomography (CT) Systems Market Pipeline Products 24

6 Financial Deals Landscape 25

6.1 Acquisition 25

6.1.1 BioTelemetry Acquires VirtualScopics for up to USD15.5 Million 25

6.2 Partnerships 27

6.2.1 Imbio and GE Healthcare Enter into Partnership 27

6.2.2 Entellus Medical Enters into Co-Marketing Agreement with Xoran Technologies 28

6.3 Venture Financing 29

6.3.1 Fresh Medical Labs Raises USD0.5 Million in Venture Financing 29

7 Recent Developments 30

7.1 Corporate Communications 30

7.1.1 Oct 24, 2016: Analogic Announces Leadership Transition 30

7.1.2 Sep 27, 2016: Camargo Pharmaceutical Services Adds to Medical Device Expertise 31

7.1.3 Sep 13, 2016: OPKO Health Appoints Jane Pine Wood as Chief Legal and Compliance Officer of BioReference Laboratories 31

7.1.4 Sep 08, 2016: iCAD Announces Management Transition 32

7.1.5 Sep 06, 2016: GSK presents positive results from phase III FULFIL study of closed triple combination therapy FF/UMEC/VI versus Symbicort Turbohaler in COPD at ERS International Congress 33

7.1.6 Sep 01, 2016: NeuroMetrix Announces Issuance of Patent for DPNCheck Core Technology in China 35

7.1.7 Aug 31, 2016: Bruce Elder Named CEO of MedQuest 36

7.1.8 Aug 10, 2016: Camargo Pharmaceutical Services Grows, Adds Three Drug Development Experts 37

7.1.9 Jul 07, 2016: Two SwedishAmerican Physician Executives Assume New Positions 37

7.1.10 Jun 13, 2016: OPKO Health Announces Move to NASDAQ Stock Market 38

7.1.11 May 25, 2016: ProLungdx Board Names Dr. John C. Ruckdeschel as Newest Board Member 38

7.1.12 May 11, 2016: Regeneron and Sanofi Genzyme to Present Additional Data from Pivotal Phase 2b Dupilumab Study in Adults with Uncontrolled Persistent Asthma at the American Thoracic Society International Conference 39

7.1.13 May 10, 2016: Cerulean Announces First Patient Dosed in Phase 1/2 Trial Evaluating CRLX101 in Combination with LYNPARZA 40

7.1.14 Apr 21, 2016: RefleXion Medical Strengthens Management Team to Bring Biology-Guided Radiotherapy Into the Clinic 42

7.1.15 Feb 25, 2016: Algobate Announces Positive Pre-Phase 3 Meeting With FDA for Naloxone PRT in Opioid Induced Constipation 43

7.1.16 Feb 22, 2016: IMRIS, Deerfield Imaging Board of Directors Appoints Andrew M. Flanagan as Chief Executive Officer 45

7.1.17 Feb 17, 2016: Alliance HealthCare Services Announces Rhonda Longmore-Grund to Assume Chief Financial Officer Role as Part of Planned Transition 45

7.1.18 Feb 08, 2016: Timothy Damadian Named President and CEO of FONAR 46

7.1.19 Jan 26, 2016: Bernard Bailey Appointed Chairman and Steve Odland Joins Analogic's Board 47

7.1.20 Jan 14, 2016: WellStar Announces New Leadership Roles 48

7.1.21 Jan 11, 2016: Bellicum Pharmaceuticals Announces regulatory milestones and program updates on its CAR T product candidate BPX-401 49

7.1.22 Dec 09, 2015: Foundation Radiology Group Announces New Board Member 50

7.1.23 Dec 09, 2015: iCAD Appoints Andrew Sassine to Board of Directors 50

7.1.24 Nov 25, 2015: Vital Images Names Dr. Paul A. Markham as Vice President of Marketing 51

7.2 Financial Announcements 51

7.2.1 Oct 27, 2016: Stryker reports third quarter 2016 results 51

7.2.2 Oct 27, 2016: Accuray Reports Financial Results for First Quarter and Affirms Full Year Fiscal 2017 Guidance 52

7.2.3 Oct 19, 2016: St. Jude Medical Reports Third Quarter 2016 Results 54

7.2.4 Sep 21, 2016: Analogic Announces Results for the Fourth Quarter and Fiscal Year Ended July 31, 2016 and Declares Quarterly Cash Dividend 55

7.2.5 Sep 19, 2016: FONAR Announces Fiscal 2016 Year End Earnings 57

7.2.6 Aug 17, 2016: Accuray Reports Fourth Quarter and Fiscal 2016 Financial Results 58

7.2.7 Aug 08, 2016: OPKO Health Reports Improved Financial and Operating Results 60

7.2.8 Aug 04, 2016: Alliance HealthCare Services Reports Results for the Second Quarter and Six Months Ended June 30, 2016 61

7.2.9 Jul 27, 2016: iCAD Reports Second Quarter 2016 Financial Results 63

7.2.10 Jul 25, 2016: Halozyme Resumes Patient Enrollment And Dosing In PEGPH20 Clinical Trial With KEYTRUDA 66

7.2.11 Jul 25, 2016: VALNEVA Announces Successful Completion of Phase II for Clostridium Difficile Vaccine Candidate 68

7.2.12 Jul 21, 2016: Stryker reports second quarter 2016 results 69

7.2.13 Jul 20, 2016: St. Jude Medical Reports Second Quarter 2016 Results 70

7.2.14 Jun 01, 2016: Analogic Announces Results for the Third Quarter Ended April 30, 2016 and Declares Quarterly Cash Dividend 72

7.2.15 May 10, 2016: FONAR Announces 3rd Quarter and Nine Months Financial Results for Fiscal 2016 73

7.2.16 May 09, 2016: OPKO Health Reports First Quarter Financial and Operating Results 75

7.2.17 May 05, 2016: Alliance HealthCare Services Reports Results for the First Quarter Ended March 31, 2016 76

7.2.18 May 03, 2016: ICAD Reports First Quarter 2016 Financial Results 78

7.2.19 Mar 10, 2016: Alliance HealthCare Services Reports Fourth Quarter & Full Year 2015 Results 80

7.2.20 Mar 02, 2016: Analogic Announces Results for the Second Quarter Ended January 31, 2016 and Declares Quarterly Cash Dividend 82

7.2.21 Mar 01, 2016: iCAD Reports Fourth Quarter and Full Year 2015 Financial Results 84

7.2.22 Feb 09, 2016: FONAR Announces Fiscal 2016 2nd Quarter and Six Months Financial Results 86

7.2.23 Nov 18, 2015: Analogic Announces Preliminary First Quarter Results and Updates Its Fiscal 2016 Outlook 87

7.2.24 Nov 09, 2015: FONAR Announces Fiscal 2016 1st Quarter Financial Results 88

7.2.25 Nov 05, 2015: Alliance HealthCare Services Reports Third Quarter 2015 Results 89

7.3 Government and Public Interest 91

7.3.1 Jun 05, 2016: LYNPARZA (olaparib): Latest Data Suggest Potential Overall Survival Advantage in Patients with Platinum Sensitive Ovarian Cancer 91

7.3.2 May 23, 2016: Teijin Pharma's Feburic (Febuxostat) Approved as Indication for Cancer Chemotherapy-Induced Hyperuricemia 93

7.3.3 May 22, 2016: Data from New Analyses of Studies with Veltassa Presented at 53rd European Renal Association Congress 94

7.3.4 Apr 25, 2016: GlycoMimetics Data on GMI-1271 Treatment of Acetaminophen-Triggered Liver Toxicity to Be Presented at "Digestive Disease Week" Conference 97

7.3.5 Apr 13, 2016: Bio Products Laboratory Announces FDA Submission of Biologics License Supplement for Gammaplex 10% 98

7.3.6 Mar 01, 2016: Nordic Nanovector: Late-Breaking Abstract on Betalutin Phase 1/2 Study Accepted for Presentation at American Association for Cancer Research Annual Meeting 2016 99

7.3.7 Jan 28, 2016: European Commission Approves Daklinza (daclatasvir) for the Treatment of Genotype 1, 3 and 4 Chronic Hepatitis C Patients with HIV Coinfection, Advanced Cirrhosis and Post-liver Transplant Recurrence of HCV 100

7.3.8 Dec 17, 2015: Preliminary 15-month results from DIABGAD - a 30-month pilot study with the diabetes vaccine Diamyd in combination with vitamin D and ibuprofen 103

7.4 Legal And Regulatory 107

7.4.1 Aug 15, 2016: Med Center Health Facilities Earn ACR Lung Cancer Screening Center Designation 107

7.5 Other Significant Developments 108

7.5.1 Jul 31, 2016: Toshiba and AHRA Open Applications for Ninth Annual Putting Patients First Program 108

7.5.2 Jun 21, 2016: iCAD Commends Final USPSTF Recommendations for Colorectal Cancer Screening Including Computed Tomography Colonography 109

7.5.3 Jun 09, 2016: NeuroMetrix Showcases Quell Technology at SLEEP 2016, the 30th Anniversary Meeting of the Associated Professional Sleep Societies 109

7.5.4 Apr 01, 2016: BTG announces US launch of LC Bead LUMI, ground-breaking radiopaque embolic bead 110

7.5.5 Mar 22, 2016: The University of Tennessee College of Medicine Launches the World's First Mobile Stroke Unit with Advanced CT Imaging Capabilities Including CT Angiography Imaging for the Brain and Blood Vessels 112

7.5.6 Jan 05, 2016: University of Iowa Hospitals and Clinics Selects Local Startup, VIDA, for Precision Pulmonology Imaging Solution 113

7.5.7 Dec 08, 2015: Analogic Announces Results for the First Quarter Ended October 31, 2015 and Declares Quarterly Cash Dividend 114

7.6 Product News 115

7.6.1 Sep 14, 2016: Fluxion Biosciences Launches IsoFlux Cytation Imager for Automated CTC Analysis 115

7.6.2 Sep 07, 2016: Bruker Unveils Next-Generation Preclinical Imaging Systems for Advanced Translational Research at World Molecular Imaging Congress 116

7.6.3 Jun 08, 2016: NICE draft recommendation on the use of aflibercept (EYLEA) for management of branch retinal vein occlusion goes against Royal College of Ophthalmologists' guidance 117

7.6.4 Apr 26, 2016: Philips receives FDA 510(k) clearance of CT imaging solutions for lung cancer screening to help hospitals of all sizes drive earlier detection and improve patient care decisions 118

7.6.5 Dec 17, 2015: Accuray Hosts First Regional Users' Meeting 119

7.7 Strategy And Business Planning 120

7.7.1 Aug 09, 2016: Hitachi Medical Releases Major Upgrade to Oasis 1.2T Open MR 120

8 Appendix 122

8.1 Research Methodology 123

8.1.1 Coverage 123

8.1.2 Secondary Research 123

8.1.3 Primary Research 124

8.1.4 Market Modeling and Forecasting 125

8.1.5 Company Share Analysis 126

8.1.6 Distribution Share Analysis 127

8.1.7 Benchmarking 127

8.2 GlobalData Consulting 127

8.3 Contact Us 128

8.4 Disclaimer 128

1.2 List of Figures

Figure 1: Computed Tomography (CT) Systems Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015 9

Figure 2: Computed Tomography (CT) Systems Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022 11

Figure 3: Computed Tomography (CT) Systems Market, United States, Volume (Units), Historic, 2008-2015 13

Figure 4: Computed Tomography (CT) Systems Market, United States, Volume (Units), Forecast, 2015-2022 15

Figure 5: Computed Tomography (CT) Systems Market, United States, Company Share (%) 2015 20

1.1 List of Tables

Table 1: Computed Tomography (CT) Systems Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015 10

Table 2: Computed Tomography (CT) Systems Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022 12

Table 3: Computed Tomography (CT) Systems Market, United States, Volume (Units), Historic, 2008-2015 14

Table 4: Computed Tomography (CT) Systems Market, United States, Volume (Units), Forecast, 2015-2022 16

Table 5: Computed Tomography (CT) Systems Market, United States, Average Price ($), Historic, 2008-2015 17

Table 6: Computed Tomography (CT) Systems Market, United States, Average Price ($), Forecast, 2015-2022 18

Table 7: Computed Tomography (CT) Systems Market, United States, Distribution Share by Revenue ($m), USD Constant, 2014-2015 19

Table 8: Computed Tomography (CT) Systems Market, United States, Company Share by Revenue ($m), USD Constant, 2015 21

Table 9: Computed Tomography (CT) Systems Market Pipeline Products 24

Table 10: BioTelemetry Acquires VirtualScopics for up to USD15.5 Million 25

Table 11: Imbio and GE Healthcare Enter into Partnership 27

Table 12: Entellus Medical Enters into Co-Marketing Agreement with Xoran Technologies 28

Table 13: Fresh Medical Labs Raises USD0.5 Million in Venture Financing 29

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Siemens Limited, GE Healthcare Limited, Toshiba Medical Systems Corporation, Philips Healthcare

Diagnostic Imaging, Angio Suites, Bone Densitometers, Computed Tomography (CT) Systems, Contrast Agents, Contrast Media Injectors, Mammography Equipment, Mobile C-Arms, MRI Systems, Nuclear Imaging Equipment, Ultrasound Systems, X-ray Systems, Value (USD), Volume (units), Revenues, Historic Revenues, Forecast Revenues, Average Price, Company Share, Distribution Share by Revenue, Company Share by Revenue, Pipeline Products, News, Deals, Key Companies, GE Healthcare Limited, Siemens Limited, Philips Healthcare, Toshiba Medical Systems Corporation, Bayer HealthCare AG, Bracco Imaging S.p.A., Hologic, Inc., Guerbet SA, Hitachi Healthcare Manufacturing, Ltd., Shimadzu Corporation, Samsung Medison Co., Ltd., Fujifilm Holdings Corporation, Carestream Health, Inc., Ziehm Imaging, Inc., Neusoft Medical Systems Co., Ltd., Allengers Medical Systems Limited, Esaote S.p.A., Jiangsu Hengrui Medicine Co., Ltd., Nemoto Kyorindo Co., Ltd., Agfa HealthCare NV


Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com